Sharon Miksys

2.5k total citations
52 papers, 2.1k citations indexed

About

Sharon Miksys is a scholar working on Pharmacology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Sharon Miksys has authored 52 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pharmacology, 20 papers in Molecular Biology and 18 papers in Cellular and Molecular Neuroscience. Recurrent topics in Sharon Miksys's work include Pharmacogenetics and Drug Metabolism (27 papers), Receptor Mechanisms and Signaling (12 papers) and Neurotransmitter Receptor Influence on Behavior (12 papers). Sharon Miksys is often cited by papers focused on Pharmacogenetics and Drug Metabolism (27 papers), Receptor Mechanisms and Signaling (12 papers) and Neurotransmitter Receptor Influence on Behavior (12 papers). Sharon Miksys collaborates with scholars based in Canada, United States and Switzerland. Sharon Miksys's co-authors include Rachel F. Tyndale, Ewa Hoffmann, Deborah C. Mash, A. S. M. Saleuddin, Edward M. Sellers, Anna Lee, Roberta M. Palmour, Lisa A. Howard, Jiang Yue and Frank J. Gonzalez and has published in prestigious journals such as PLoS ONE, Brain Research and Journal of Neurochemistry.

In The Last Decade

Sharon Miksys

51 papers receiving 2.0k citations

Peers

Sharon Miksys
Paul Skett United Kingdom
Megan Roth United States
Robert E. Stitzel United States
Joseph Cochin United States
J. Mitchell United Kingdom
Sharon Miksys
Citations per year, relative to Sharon Miksys Sharon Miksys (= 1×) peers Kenichi Kitani

Countries citing papers authored by Sharon Miksys

Since Specialization
Citations

This map shows the geographic impact of Sharon Miksys's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Miksys with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Miksys more than expected).

Fields of papers citing papers by Sharon Miksys

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon Miksys. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Miksys. The network helps show where Sharon Miksys may publish in the future.

Co-authorship network of co-authors of Sharon Miksys

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon Miksys. A scholar is included among the top collaborators of Sharon Miksys based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon Miksys. Sharon Miksys is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miksys, Sharon, et al.. (2024). Human CYP2D6 varies across the estrous cycle in brains of transgenic mice altering drug response. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 135. 111108–111108.
2.
Miksys, Sharon, et al.. (2020). Human CYP2D6 Is Functional in Brain In Vivo: Evidence from Humanized CYP2D6 Transgenic Mice. Molecular Neurobiology. 57(6). 2509–2520. 13 indexed citations
3.
Hasbi, Ahmed, Tuan Nguyen, Sharon Miksys, et al.. (2020). Sex difference in dopamine D1-D2 receptor complex expression and signaling affects depression- and anxiety-like behaviors. Biology of Sex Differences. 11(1). 8–8. 63 indexed citations
4.
Miksys, Sharon, et al.. (2020). The Influence of Tobacco Smoke/Nicotine on CYP2A Expression in Human and African Green Monkey Lungs. Molecular Pharmacology. 98(6). 658–668. 3 indexed citations
5.
Miksys, Sharon, et al.. (2013). Ethanol self-administration and nicotine treatment induce brain levels of CYP2B6 and CYP2E1 in African green monkeys. Neuropharmacology. 72. 74–81. 23 indexed citations
6.
Cheng, Jie, Sharon Miksys, Diren Beyoğlu, et al.. (2013). Potential role of CYP2D6 in the central nervous system. Xenobiotica. 43(11). 973–984. 57 indexed citations
7.
Miksys, Sharon, Susanne L.T. Cappendijk, William M. Perry, Bin Zhao, & Rachel F. Tyndale. (2013). Nicotine Kinetics in Zebra Finches In Vivo and In Vitro. Drug Metabolism and Disposition. 41(6). 1240–1246. 1 indexed citations
8.
Miksys, Sharon & Rachel F. Tyndale. (2013). Cytochrome P450–mediated drug metabolism in the brain. Journal of Psychiatry and Neuroscience. 38(3). 152–163. 105 indexed citations
9.
Mahar, Ian, Rosemary C. Bagot, Maria Antonietta Davoli, et al.. (2012). Developmental Hippocampal Neuroplasticity in a Model of Nicotine Replacement Therapy during Pregnancy and Breastfeeding. PLoS ONE. 7(5). e37219–e37219. 18 indexed citations
10.
Mann, Amandeep, Sharon Miksys, Andrea Gaedigk, et al.. (2011). The neuroprotective enzyme CYP2D6 increases in the brain with age and is lower in Parkinson's disease patients. Neurobiology of Aging. 33(9). 2160–2171. 77 indexed citations
11.
Khokhar, Jibran Y., Sharon Miksys, & Rachel F. Tyndale. (2010). Rat brain CYP2B induction by nicotine is persistent and does not involve nicotinic acetylcholine receptors. Brain Research. 1348. 1–9. 16 indexed citations
12.
Yue, Jiang, Jibran Y. Khokhar, Sharon Miksys, & Rachel F. Tyndale. (2009). Differential induction of ethanol-metabolizing CYP2E1 and nicotine-metabolizing CYP2B1/2 in rat liver by chronic nicotine treatment and voluntary ethanol intake. European Journal of Pharmacology. 609(1-3). 88–95. 29 indexed citations
13.
Miksys, Sharon & Rachel F. Tyndale. (2008). Brain Drug-Metabolizing Cytochrome P450 Enzymes are Active In Vivo, Demonstrated by Mechanism-Based Enzyme Inhibition. Neuropsychopharmacology. 34(3). 634–640. 49 indexed citations
14.
Lee, Anna, Sharon Miksys, & Rachel F. Tyndale. (2006). Phenobarbital increases monkeyin vivonicotine disposition and induces liver and brain CYP2B6 protein. British Journal of Pharmacology. 148(6). 786–794. 17 indexed citations
15.
Miksys, Sharon & Rachel F. Tyndale. (2006). Nicotine induces brain CYP enzymes: relevance to Parkinson’s disease. PubMed. 177–180. 53 indexed citations
16.
Lee, Anna, Sharon Miksys, Roberta M. Palmour, & Rachel F. Tyndale. (2005). CYP2B6 is expressed in African Green monkey brain and is induced by chronic nicotine treatment. Neuropharmacology. 50(4). 441–450. 35 indexed citations
17.
Miksys, Sharon. (2003). Smoking, alcoholism and genetic polymorphisms alter CYP2B6 levels in human brain. Neuropharmacology. 45(1). 122–132. 165 indexed citations
18.
Miksys, Sharon, et al.. (2003). Rat Hepatic CYP2E1 Is Induced by Very Low Nicotine Doses: An Investigation of Induction, Time Course, Dose Response, and Mechanism. Journal of Pharmacology and Experimental Therapeutics. 306(3). 941–947. 41 indexed citations
19.
Miksys, Sharon, et al.. (2002). Regional and cellular expression of CYP2D6 in human brain: higher levels in alcoholics. Journal of Neurochemistry. 82(6). 1376–1387. 125 indexed citations
20.
Miksys, Sharon & Ian Orchard. (1994). Immunogold labelling of serotonin-like and FMRFamide-like immunoreactive material in neurohaemal areas on abdominal nerves of Rhodnius prolixus. Cell and Tissue Research. 278(1). 145–151. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026